Literature DB >> 17957030

Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells.

Markus Mezger1, Michael Steffens, Melanie Beyer, Carolin Manger, Johannes Eberle, Mohammad-Reza Toliat, Thomas F Wienker, Per Ljungman, Holger Hebart, Hans Jürgen Dornbusch, Hermann Einsele, Juergen Loeffler.   

Abstract

Patients after allogeneic stem-cell transplantation (alloSCT) have an increased risk for invasive aspergillosis (IA). Here, recipients of an allograft with IA (n=81) or without IA (n=58) were screened for 84 single nucleotide polymorphisms in 18 immune relevant genes. We found 3 markers in chemokine (C-X-C motif) ligand 10 (CXCL10, 4q21, 11,101 C>T, P=.007; 1642 C<G, P=.003; -1101 A<G, P=.001) significantly associated with an increased risk of developing IA. Furthermore, immature dendritic cells (iDCs) exposed to Aspergillus fumigatus germlings showed markedly higher CXCL10 expression, if carrying the wild type genotype, compared with the "CGAG" high risk haplotype. In addition, serum from patients with proven/probable IA showed increased serum levels of CXCL10, compared with immunocompromised patients without IA. Thus, polymorphisms in CXCL10 determine chemokine secretion by iDCs upon exposure to A fumigatus and most likely thereby genetically determine the risk of IA after alloSCT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957030     DOI: 10.1182/blood-2007-05-090928

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

Review 1.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

2.  Genetic Susceptibility to Fungal Infections in Humans.

Authors:  Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2011-12-15

3.  Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

Authors:  Cynthia E Fisher; Tobias M Hohl; Wenhong Fan; Barry E Storer; David M Levine; Lu Ping Zhao; Paul J Martin; Edus H Warren; Michael Boeckh; John A Hansen
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

Review 4.  Host genetics of invasive Aspergillus and Candida infections.

Authors:  Agnieszka Wójtowicz; Pierre-Yves Bochud
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

Review 5.  Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.

Authors:  Christopher C Dvorak; Brian T Fisher; Lillian Sung; William J Steinbach; Michael Nieder; Sarah Alexander; Theoklis E Zaoutis
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

Review 6.  Risk stratification and immunogenetic risk for infections following stem cell transplantation.

Authors:  Agnieszka Wójtowicz; Pierre-Yves Bochud
Journal:  Virulence       Date:  2016-09-09       Impact factor: 5.882

7.  Genetic Susceptibility to Fungal Infections: What is in the Genes?

Authors:  Stacey A Maskarinec; Melissa D Johnson; John R Perfect
Journal:  Curr Clin Microbiol Rep       Date:  2016-03-29

Review 8.  Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies.

Authors:  Nadia Al-Bader; Donald C Sheppard
Journal:  Virulence       Date:  2016-09-29       Impact factor: 5.882

9.  Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice.

Authors:  Hemanth Ramaprakash; Toshihiro Ito; Theodore J Standiford; Steven L Kunkel; Cory M Hogaboam
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

10.  Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis.

Authors:  M Jurado; J Sainz; C B Lupiañez; M Martínez-Bueno; J M Sánchez-Maldonado; J Badiola; C Cunha; J Springer; M Lackner; J Segura-Catena; L M Canet; L Alcazar-Fuoli; M A López-Nevot; L Fianchi; J M Aguado; L Pagano; E López-Fernández; M Alarcón-Riquelme; L Potenza; S M Gonçalves; M Luppi; L Moratalla; C Solano; A Sampedro; P González-Sierra; M Cuenca-Estrella; K Lagrou; J A Maertens; C Lass-Flörl; H Einsele; L Vazquez; J Loeffler; R Ríos-Tamayo; A Carvalho
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.